Selected research
Industry Growth & Trends
Global Nattokinase Industry Growth and Trends Forecast to 2032
Market perspective
The global Nattokinase market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Nattokinase is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Nattokinase is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Nattokinase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Nattokinase include Contek Life Science, Daiwa Pharmaceutical, Japan Bio Science Laboratory and Sungen Bioscience, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Nattokinase market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Nattokinase market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nattokinase market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nattokinase.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Nattokinase market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Nattokinase Market by Company
Contek Life Science
Daiwa Pharmaceutical
Japan Bio Science Laboratory
Sungen Bioscience
Nattokinase Segment by Type
Above 20001 Fu/g
10001-20000 Fu/g
0-10000 Fu/g
Nattokinase Segment by Application
Dietary Supplement
Others
Nattokinase Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nattokinase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nattokinase and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nattokinase.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nattokinase manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Nattokinase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Above 20001 Fu/g
- 10001-20000 Fu/g
- 0-10000 Fu/g
Applications
- Dietary Supplement
- Others
Companies covered
- Contek Life Science
- Daiwa Pharmaceutical
- Japan Bio Science Laboratory
- Sungen Bioscience
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Nattokinase Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Nattokinase Sales Estimates and Forecasts (2021-2032)
- 1.3 Nattokinase Market by Type
- 1.3.1 Above 20001 Fu/g
- 1.3.2 10001-20000 Fu/g
- 1.3.3 0-10000 Fu/g
- 1.4 Global Nattokinase Market Size by Type
- 1.4.1 Global Nattokinase Market Size Overview by Type (2021-2032)
- 1.4.2 Global Nattokinase Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Nattokinase Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Nattokinase Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Nattokinase Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Nattokinase Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Nattokinase Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Nattokinase Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Nattokinase Industry Trends
- 2.2 Nattokinase Industry Drivers
- 2.3 Nattokinase Industry Opportunities and Challenges
- 2.4 Nattokinase Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Nattokinase Revenue (2021-2026)
- 3.2 Global Top Players by Nattokinase Sales (2021-2026)
- 3.3 Global Top Players by Nattokinase Price (2021-2026)
- 3.4 Global Nattokinase Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Nattokinase Major Company Production Sites & Headquarters
- 3.6 Global Nattokinase Company, Product Type & Application
- 3.7 Global Nattokinase Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Nattokinase Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Nattokinase Players Market Share by Revenue in 2025
- 3.8.3 2025 Nattokinase Tier 1, Tier 2, and Tier 3
4 Nattokinase Regional Status and Outlook
- 4.1 Global Nattokinase Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Nattokinase Historic Market Size by Region
- 4.2.1 Global Nattokinase Sales in Volume by Region (2021-2026)
- 4.2.2 Global Nattokinase Sales in Value by Region (2021-2026)
- 4.2.3 Global Nattokinase Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Nattokinase Forecasted Market Size by Region
- 4.3.1 Global Nattokinase Sales in Volume by Region (2027-2032)
- 4.3.2 Global Nattokinase Sales in Value by Region (2027-2032)
- 4.3.3 Global Nattokinase Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Nattokinase by Application
- 5.1 Nattokinase Market by Application
- 5.1.1 Dietary Supplement
- 5.1.2 Others
- 5.2 Global Nattokinase Market Size by Application
- 5.2.1 Global Nattokinase Market Size Overview by Application (2021-2032)
- 5.2.2 Global Nattokinase Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Nattokinase Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Nattokinase Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Nattokinase Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Nattokinase Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Nattokinase Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Nattokinase Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Contek Life Science
- 6.1.1 Contek Life Science Company Information
- 6.1.2 Contek Life Science Business Overview
- 6.1.3 Contek Life Science Nattokinase Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Contek Life Science Nattokinase Product Portfolio
- 6.1.5 Contek Life Science Recent Developments
- 6.2 Daiwa Pharmaceutical
- 6.2.1 Daiwa Pharmaceutical Company Information
- 6.2.2 Daiwa Pharmaceutical Business Overview
- 6.2.3 Daiwa Pharmaceutical Nattokinase Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Daiwa Pharmaceutical Nattokinase Product Portfolio
- 6.2.5 Daiwa Pharmaceutical Recent Developments
- 6.3 Japan Bio Science Laboratory
- 6.3.1 Japan Bio Science Laboratory Company Information
- 6.3.2 Japan Bio Science Laboratory Business Overview
- 6.3.3 Japan Bio Science Laboratory Nattokinase Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Japan Bio Science Laboratory Nattokinase Product Portfolio
- 6.3.5 Japan Bio Science Laboratory Recent Developments
- 6.4 Sungen Bioscience
- 6.4.1 Sungen Bioscience Company Information
- 6.4.2 Sungen Bioscience Business Overview
- 6.4.3 Sungen Bioscience Nattokinase Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Sungen Bioscience Nattokinase Product Portfolio
- 6.4.5 Sungen Bioscience Recent Developments
7 North America by Country
- 7.1 North America Nattokinase Sales by Country
- 7.1.1 North America Nattokinase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Nattokinase Sales by Country (2021-2026)
- 7.1.3 North America Nattokinase Sales Forecast by Country (2027-2032)
- 7.2 North America Nattokinase Market Size by Country
- 7.2.1 North America Nattokinase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Nattokinase Market Size by Country (2021-2026)
- 7.2.3 North America Nattokinase Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Nattokinase Sales by Country
- 8.1.1 Europe Nattokinase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Nattokinase Sales by Country (2021-2026)
- 8.1.3 Europe Nattokinase Sales Forecast by Country (2027-2032)
- 8.2 Europe Nattokinase Market Size by Country
- 8.2.1 Europe Nattokinase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Nattokinase Market Size by Country (2021-2026)
- 8.2.3 Europe Nattokinase Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Nattokinase Sales by Country
- 9.1.1 Asia-Pacific Nattokinase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Nattokinase Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Nattokinase Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Nattokinase Market Size by Country
- 9.2.1 Asia-Pacific Nattokinase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Nattokinase Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Nattokinase Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Nattokinase Sales by Country
- 10.1.1 South America Nattokinase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Nattokinase Sales by Country (2021-2026)
- 10.1.3 South America Nattokinase Sales Forecast by Country (2027-2032)
- 10.2 South America Nattokinase Market Size by Country
- 10.2.1 South America Nattokinase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Nattokinase Market Size by Country (2021-2026)
- 10.2.3 South America Nattokinase Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Nattokinase Sales by Country
- 11.1.1 Middle East and Africa Nattokinase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Nattokinase Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Nattokinase Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Nattokinase Market Size by Country
- 11.2.1 Middle East and Africa Nattokinase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Nattokinase Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Nattokinase Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Nattokinase Value Chain Analysis
- 12.1.1 Nattokinase Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Nattokinase Production Mode & Process
- 12.2 Nattokinase Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Nattokinase Distributors
- 12.2.3 Nattokinase Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst